The assessment of rare adverse events following vaccination may not be possible within a
single country due to an insufficiently large denominator population. In 2008 a European …

OBJECTIVE: To determine the incidence of immune thrombocytopenic purpura (ITP) after
measles-mumps-rubella (MMR) immunization compared with natural measles and rubella …

BACKGROUND. The measles-mumps-rubella vaccine has been associated with immune
thrombocytopenia purpura in 2 small studies. METHODS. By using the Vaccine Safety …

An increasing body of evidence has been gathered since the mid-1960s to support a link
between vaccinations, particularly the measles-mumps-rubella (MMR) vaccine and …

In a review of adverse events associated with childhood vaccines, the Vaccine Safety
Committee of the Institute of Medicine (IOM) in 1993 concluded that a causal relationship …

Background Thrombocytopenic purpura (TP) after vaccination with measles, mumps and
rubella has occasionally been reported. Objectives To evaluate the incidence and …

Background. Several disorders have been attributed to measles-mumps-rubella (MMR)
vaccination during the past decade. The aim of this prospective follow-up study was to …

We describe a new method for active post-marketing surveillance of vaccine safety based on
patient records. We studied the association between diphtheria/tetanus/pertussis (DTP) …

A retrospective epidemiological survey was conducted to evaluate the incidence and
characteristics of thrombocytopenic purpura (TP) reported in France following measles …

Abstract Measles-mumps-rubella (MMR) vaccines containing the Urabe strain of mumps
were withdrawn in the United Kingdom in 1992 following demonstration of an increased risk …